Literature DB >> 2801740

Rhabdomyolysis in pneumococcal sepsis.

J E Naschitz1, D Yeshurun, I Shagrawi.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2801740     DOI: 10.1016/s0002-9343(89)80842-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  A rare association of rhabdomyolysis and purpura fulminans in Strep. pneumoniae septicemia.

Authors:  E L Marcus; M Hersch; M Sonnenblick
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 2.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  Skeletal muscle oedema and muscle fibre necrosis during septic shock. Observations with a porcine septic shock model.

Authors:  S Hauptmann; B Klosterhalfen; J Weis; C Mittermayer; C J Kirkpatrick
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 4.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097

Review 5.  Potential factors involved in the causation of rhabdomyolysis following status asthmaticus.

Authors:  Hongmei Qiao; Huanji Cheng; Li Liu; Jianing Yin
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-22       Impact factor: 3.406

Review 6.  A Klebsiella pneumoniae liver abscess presenting with myasthenia and tea-colored urine: A case report and review of 77 cases of bacterial rhabdomyolysis.

Authors:  Lihua Deng; Rong Jia; Wei Li; Qian Xue; Jie Liu; Yide Miao; Jingtong Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).

Authors:  Kok Hoe Chan; Iyad Farouji; Amany Abu Hanoud; Jihad Slim
Journal:  Am J Emerg Med       Date:  2020-05-11       Impact factor: 2.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.